Invention Grant
- Patent Title: Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
-
Application No.: US15831100Application Date: 2017-12-04
-
Publication No.: US10023614B2Publication Date: 2018-07-17
- Inventor: Ashok Bhandari , Gregory Bourne , Xiaoli Cheng , Brian Troy Frederick , Jie Zhang , Dinesh V. Patel , David Liu
- Applicant: Protagonist Therapeutics, Inc.
- Applicant Address: US CA Newark
- Assignee: Protagonist Therapeutics, Inc.
- Current Assignee: Protagonist Therapeutics, Inc.
- Current Assignee Address: US CA Newark
- Agency: Cooley LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K7/02 ; C07K7/08 ; C07K7/50 ; C07K7/64 ; C07K14/47 ; C07K14/54
Abstract:
Peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease, are disclosed.
Public/Granted literature
- US20180079783A1 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES Public/Granted day:2018-03-22
Information query
IPC分类:
